LUMO - Lumos Pharma Inc. (LUMO) Q4 2023 Earnings Call Transcript
2024-03-07 17:45:08 ET
Lumos Pharma, Inc. (LUMO)
Q4 2023 Earnings Conference
March 07, 2024 04:30 PM ET
Company Participants
Lisa Miller - Vice President, IR
Rick Hawkins - CEO and Chairman
John McKew - President and CSO
Duke Pitukcheewanont - CMO
Lori Lawley - CFO
Conference Call Participants
Charles Duncan - Cantor Fitzgerald
Leland Gershell - Oppenheimer
Ed White - H.C. Wainwright
Catherine Novack - Jones Trading
Presentation
Operator
Good afternoon and welcome to Lumos Pharma’s 2023 Fourth Quarter and Year End Conference Call. Currently all participants are on a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference call is being recorded.
I will now turn the call over to Lisa Miller, Vice President of Investor Relations. Please go ahead.
Lisa Miller
Thank you, operator. Before we proceed with this call, I'd like to remind everyone that certain statements made during this call are forward-looking statements under U.S. Federal Securities Laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. Additional information concerning factors that could cause actual results to differ is contained in our periodic reports filed with the SEC. The forward-looking statements made during this call speak only as of the date hereof, and the company undertakes no obligation to update or revise the forward-looking statements. Information presented on this call is contained in the press release we issued this afternoon and in our forum 10-K which may be accessed from the investors page of the company's website....
Lumos Pharma, Inc. (LUMO) Q4 2023 Earnings Call Transcript